Skip to content
ChickenStockChickenStock
ResearchFilings

AI English summary of an SEC filing — figures as filed

The Estée Lauder Companies logoThe Estée Lauder Companies EL

The Estée Lauder Companies said net sales for the fiscal year ended June 30, 2024 fell to $15.61 billion from $15.91 billion a year earlier, a decrease of 2%, and diluted net earnings per common share declined to $1.08 from $2.79.

8-KResults of Operations and Financial ConditionFiled Period of report Summary published (UTC)

Key points

AI summary
  1. The Estée Lauder Companies said net sales for the fiscal year ended June 30, 2024 fell to $15.61 billion from $15.91 billion a year earlier, a decrease of 2%, and diluted net earnings per common share declined to $1.08 from $2.79.

  2. The company said it recorded full-year goodwill and other intangible asset impairment charges of $471 million related to Dr.Jart+, and adjusted diluted net earnings per common share, which excludes those charges, were $2.59, down 25% from $3.46 a year earlier.

  3. Estée Lauder said net cash provided by operating activities for the 12 months ended June 30, 2024 was $2.36 billion, up from $1.73 billion a year earlier, and it ended the year with cash and cash equivalents of $3.40 billion and paid dividends of $0.95 billion.

  4. The company said it expects reported and organic net sales for fiscal 2025 to range from a decrease of 1% to an increase of 2%, adjusted operating margin of 11.0% to 11.5%, and net cash provided by operating activities of $1.8 billion to $2.0 billion.

Summary

AI-written

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

Annual Net Sales and Diluted EPS Decline

The Estée Lauder Companies said net sales for the fiscal year ended June 30, 2024 fell to $15.61 billion from $15.91 billion a year earlier, a decrease of 2%, and diluted net earnings per common share declined to $1.08 from $2.79.

Source · Based on the filing body and exhibits

Dr.Jart+ Impairments and Adjusted Diluted EPS

The company said it recorded full-year goodwill and other intangible asset impairment charges of $471 million related to Dr.Jart+, and adjusted diluted net earnings per common share, which excludes those charges, were $2.59, down 25% from $3.46 a year earlier.

Source · Based on the filing body and exhibits

Full-Year Operating Cash Flow and Cash Balance

Estée Lauder said net cash provided by operating activities for the 12 months ended June 30, 2024 was $2.36 billion, up from $1.73 billion a year earlier, and it ended the year with cash and cash equivalents of $3.40 billion and paid dividends of $0.95 billion.

Source · Based on the filing body and exhibits

Fiscal 2025 Full-Year Outlook

The company said it expects reported and organic net sales for fiscal 2025 to range from a decrease of 1% to an increase of 2%, adjusted operating margin of 11.0% to 11.5%, and net cash provided by operating activities of $1.8 billion to $2.0 billion.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

Source: SEC EDGAR (U.S. Securities and Exchange Commission). Item captions are the SEC's. The summary is for reference only and is not investment advice.